Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex

Hyuk Soon Kim; Geunwoong Noh

doi:10.1002/ccr3.6885

Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex

Clin Case Rep. 2023 Jan 20;11(1):e6885. doi: 10.1002/ccr3.6885. eCollection 2023 Jan.

Authors

Hyuk Soon Kim^{1

2}, Geunwoong Noh³

Affiliations

¹ Department of Biomedical Sciences, College of Natural Science The Graduate School of Dong-A University Busan Korea.
² Department of Health Sciences The Graduate School of Dong-A University Busan Korea.
³ Department of Allergy and Clinical Immunology Cheju Halla General Hospital Jeju-si Korea.

Abstract

Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen-specific antinociceptive effect in the treatment of histamine-mediated pain.

Keywords: abdominal pain; antinociceptive effects; immunoglobulin/histamine complex; monosodium glutamate; primary eosinophilic colitis.

Publication types

Case Reports